Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (431-440 of 555) with videos related to

Pageof 56
Sort By:
Cell Adhesion & Migration|October 7, 2011
Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumorsLuydmila A Mostovich, Tatiana Y Prudnikova, Aleksandr G Kondratov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2023
Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancyIsabella C Young, Aryani Pallerla, Mackenzie L Cottrell, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2019
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure ProphylaxisNithya Srinivas, Mackenzie Cottrell, Kaitlyn Maffuid, et al.
AIDS and Behavior|July 26, 2023
Feasibility, Acceptability and Appropriateness of MedViewer: A Novel Hair-Based Antiretroviral Real-Time Clinical Monitoring Tool Providing Adherence Feedback to Patients and Their ProvidersCarol E Golin, Elias P Rosen, Ella Gillespie Ferguson, et al.
Cancer Research|September 18, 2004
Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3CJingfeng Li, Fuli Wang, Klas Haraldson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2019
Antiretroviral Drug Concentrations in Lymph Nodes: A Cross-Species Comparison of the Effect of Drug Transporter Expression, Viral Infection, and Sex in Humanized Mice, Nonhuman Primates, and HumansErin Burgunder, John K Fallon, Nicole White, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected womenRosa F Yeh, Naser L Rezk, Angela D M Kashuba, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) studyDavid A Wohl, Julie B Dumond, Suzanne Blevins, et al.
Clinical Pharmacology and Therapeutics|January 9, 2023
A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood SpotsAaron S Devanathan, Julie B Dumond, Daijha J C Anderson, et al.
Research Square|June 12, 2026
First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapyJose Molto, Elias Rosen, Stephen Bondoc, et al.
Pageof 56

Showing results (431-440 of 555) with videos related to

Sort By:
Pageof 56
Cell Adhesion & Migration|October 7, 2011
Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumorsLuydmila A Mostovich, Tatiana Y Prudnikova, Aleksandr G Kondratov, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2023
Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancyIsabella C Young, Aryani Pallerla, Mackenzie L Cottrell, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2019
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure ProphylaxisNithya Srinivas, Mackenzie Cottrell, Kaitlyn Maffuid, et al.
AIDS and Behavior|July 26, 2023
Feasibility, Acceptability and Appropriateness of MedViewer: A Novel Hair-Based Antiretroviral Real-Time Clinical Monitoring Tool Providing Adherence Feedback to Patients and Their ProvidersCarol E Golin, Elias P Rosen, Ella Gillespie Ferguson, et al.
Cancer Research|September 18, 2004
Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3CJingfeng Li, Fuli Wang, Klas Haraldson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2019
Antiretroviral Drug Concentrations in Lymph Nodes: A Cross-Species Comparison of the Effect of Drug Transporter Expression, Viral Infection, and Sex in Humanized Mice, Nonhuman Primates, and HumansErin Burgunder, John K Fallon, Nicole White, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected womenRosa F Yeh, Naser L Rezk, Angela D M Kashuba, et al.
Antimicrobial Agents and Chemotherapy|November 28, 2012
Raltegravir pharmacokinetics in treatment-naive patients is not influenced by race: results from the raltegravir early therapy in African-Americans living with HIV (REAL) studyDavid A Wohl, Julie B Dumond, Suzanne Blevins, et al.
Clinical Pharmacology and Therapeutics|January 9, 2023
A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood SpotsAaron S Devanathan, Julie B Dumond, Daijha J C Anderson, et al.
Research Square|June 12, 2026
First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapyJose Molto, Elias Rosen, Stephen Bondoc, et al.
Pageof 56